ABOUT THIS EVENT

NGM Biopharmaceuticals, Inc. (Nasdaq: NGM), a clinical stage biopharmaceutical company focused on developing novel therapeutics based on scientific understanding of key biological pathways underlying cardio-metabolic, liver, oncologic and ophthalmic diseases, visited the Nasdaq MarketSite in Times Square.

In honor of the occasion, David J. Woodhouse, Ph.D., CEO, and Jin-Long Chen, Ph.D., Founder and Chief Scientific Officer, rang the Opening Bell.